Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus

Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus

US Patent 6693094 · Granted Feb 17, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Unit dosage forms for the treatment of herpes simplex2008
Unit dosage forms for the treatment of herpes simplex2008
Formulations for the prevention and treatment of insulin resistance and type 2 d2006
Formulations for the prevention and treatment of insulin resistance and type 2 d2006
Formulations for the treatment of insulin resistance and type 2 diabetes mellitu2004
Formulations for the treatment of insulin resistance and type 2 diabetes mellitu2004
Unit dosage forms for the treatment of herpes simplex2003
Unit dosage forms for the treatment of herpes simplex2003
Various thiol complexes, processes for their synthesis and clinical applications2003
Various thiol complexes, processes for their synthesis and clinical applications2003
Dosage forms useful for modifying conditions and functions associated with heari2003
Dosage forms useful for modifying conditions and functions associated with heari2003